2/24
08:00 am
inab
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
Medium
Report
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
2/9
08:58 am
inab
IN8bio promotes COO to president & COO [Seeking Alpha]
Low
Report
IN8bio promotes COO to president & COO [Seeking Alpha]
2/9
08:00 am
inab
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
Low
Report
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
2/3
08:00 am
inab
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
Low
Report
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
1/24
05:08 am
inab
IN8bio (NASDAQ:INAB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
Medium
Report
IN8bio (NASDAQ:INAB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
1/17
06:56 am
inab
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research to a "hold" rating.
1/12
08:55 am
inab
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma [Yahoo! Finance]
Medium
Report
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma [Yahoo! Finance]
1/12
08:00 am
inab
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
High
Report
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
5/7/2025
04:00 pm
inab
in8bio, inc.
MISS
Report
2.1%
in8bio, inc.
3/13/2025
04:05 pm
inab
in8bio, inc.
MISS
Report
-0.4%
in8bio, inc.
3/13/2025
04:05 pm
inab
in8bio, inc.
MISS
Report
-0.4%
in8bio, inc.
3/13/2025
04:05 pm
inab
in8bio, inc.
MISS
Report
-0.4%
in8bio, inc.
3/2
02:01 pm
inab
Form SCHEDULE 13G IN8BIO, INC. Filed by: LYTTON LAURENCE W
Neutral
Report
Form SCHEDULE 13G IN8BIO, INC. Filed by: LYTTON LAURENCE W
2/27
04:08 pm
inab
Form 8-K IN8BIO, INC. For: Feb 26
Low
Report
Form 8-K IN8BIO, INC. For: Feb 26
2/17
04:42 pm
inab
Form SCHEDULE 13G IN8BIO, INC. Filed by: Alyeska Investment Group, L.P.
Low
Report
Form SCHEDULE 13G IN8BIO, INC. Filed by: Alyeska Investment Group, L.P.
2/9
08:31 am
inab
Form 8-K IN8BIO, INC. For: Feb 04
Low
Report
Form 8-K IN8BIO, INC. For: Feb 04
2/6
04:31 pm
inab
Form 4 IN8BIO, INC. For: Feb 04 Filed by: McCall Patrick
Low
Report
Form 4 IN8BIO, INC. For: Feb 04 Filed by: McCall Patrick
2/6
04:31 pm
inab
Form 4 IN8BIO, INC. For: Feb 04 Filed by: Lamb Lawrence
Low
Report
Form 4 IN8BIO, INC. For: Feb 04 Filed by: Lamb Lawrence
2/6
04:31 pm
inab
Form 4 IN8BIO, INC. For: Feb 04 Filed by: Rochlin Kate
Low
Report
Form 4 IN8BIO, INC. For: Feb 04 Filed by: Rochlin Kate
2/6
04:31 pm
inab
Form 4 IN8BIO, INC. For: Feb 04 Filed by: Ho William Tai-Wei
Low
Report
Form 4 IN8BIO, INC. For: Feb 04 Filed by: Ho William Tai-Wei
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register